Acquisition by Chen Bihua of 1388887 shares of Erasca subject to Rule 16b-3

CRXMDelisted Stock  USD 0.0001  0.00  0.00%   
About 56% of Taxus Cardium's investor base is looking to short. The analysis of overall sentiment of trading Taxus Cardium Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. Taxus Cardium's investing sentiment overview a quick insight into current market opportunities from investing in Taxus Cardium Pharmaceuticals. Many technical investors use Taxus Cardium Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Taxus Cardium pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Taxus daily returns and investor perception about the current price of Taxus Cardium Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by Erasca Inc Director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Erasca insider trading alert for acquisition of series b-2 convertible preferred stock by Chen Bihua, Director, on 3rd of December 2024. This event was filed by Erasca Inc with SEC on 2021-07-20. Statement of changes in beneficial ownership - SEC Form 4

Taxus Cardium Fundamental Analysis

We analyze Taxus Cardium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Taxus Cardium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Taxus Cardium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Taxus Cardium is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Taxus Cardium Pharma Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Taxus Cardium pink sheet to make a market-neutral strategy. Peer analysis of Taxus Cardium could also be used in its relative valuation, which is a method of valuing Taxus Cardium by comparing valuation metrics with similar companies.

Peers

Taxus Cardium Related Equities

RAREUltragenyx   4.47   
26.0%
RVMDRevolution Medicines   4.85   
28.0%
BPMCBlueprint Medicines   4.87   
29.0%
ERASErasca   5.32   
31.0%
AKBAAkebia Ther   5.88   
35.0%
REPLReplimune   6.57   
39.0%
KYMRKymera Therapeutics   7.66   
45.0%
GLUEMonte Rosa   8.34   
49.0%
SANASana Biotechnology   11.52   
68.0%
CABACabaletta Bio   16.73   
100.0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Taxus Pink Sheet

If you are still planning to invest in Taxus Cardium Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taxus Cardium's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years